TF and brain cancer: Similar results were reported with transferrin-targeted PTX-NLC where the observed inhibition in U-87 brain cancer cell growth was solely attributed to the conjugation with transferrin while non-targeted PTX-loaded NLCs exhibited a surprising increase in cell viability [94].